Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Guess it's all relative, personally I'm ok with Craig's holding (2.3%) and renumeration.
I don't know Craig's background, but he may not have a spare 1M lying around to buy in another 5%, most people don't and he is working a job just like the majority of us.
Total renumeration is £132.7k (source: simplywallstreet), that'll include salary+pension+shares+benefits, it's a good package don't get me wrong, deffo above average, but 'the average' doesn't have a tech company to run.
The RNS states:
"It has been agreed between Kodal and Hainan that any offtake agreement reached between KMUK and Hainan Group will be based on market prices for spodumene..."
So, no, not at a premium, but based on market prices. Not unreasonable IMO
Hunt's also announced a new £5k pa ISA, which sits in addition to the current ISA allowance (20+5 pa), for investment in UK companies.
Detail needed (like how is UK company to be defined), but sounds to me like good news for RR, and a sensible move from the wider UK point-of-view.
Speaking as a chemist who develops sensor materials (albeit completely different material to QD's, and different sensing target). IMO:
I would be cautious about inferring much about sensing from what we know about display (either technicals or commercials). It's likely the QD's for IR sensing are different to those in display and so there's no comparison. On paper they may be the same (chemical constituents, chemical structure) but size, shape, purity, nature of impurities, carrier matrix/fluid, density in the matrix... all likely to be different and tailored to use.
I would expect them to be priced based on 'value' rather than 'cost' (Merck/Sigma sell volume chemicals, and are priced differently, it's a different league). I.e. how much are THESE dots, that do things no other dots can do, worth to YOUR product... and I guess unless one is privy to the commercial agreements or it's announced by either party, we'll probably never know!
I know we don't supply engines for Airbus's narrow body equivalent to the 737max, but if airlines stop buying the max and turn to alternatives they have Airbus choices. #1 like for like narrow body, with associated long lead-times (years?). #2 pivot strategy and buy (fewer) wide bodies which have a smaller orderbook.
So in my mind I can see scenarios where the lack of Boeing narrow body deliveries leads to an increase in Airbus widebody builds, possibly using RR engines.
Speculation I admit (and I'm no aviation industry expert!).
Apologies if already posted (been out of these boards last few days). This popped up on LinkedIn: https://www.linkedin.com/news/story/boeings-24-goals-murky-amid-probe-5922796/?utm_source=rss&utm_campaign=storylines_en&utm_medium=google_news
Boeing not offering financial or operational goals for '24 until things are more ship shape.
Not so sure, just read the updated story (BBC) with images, you can't see the wing through the gap, normally the exits are right on the wing (not flown 737 max yet though, and am no expert on their design).
Nice neat edges though, so it's a complete section that's popped off rather than ripped off.
The airline has grounded all it's 60odd 737's pending inspections.
I'm flying to New Mexico next week... hopefully in an Airbus...
In competitor news (i.e. nothing to do with engines and doesn't even use RR engines) looks like a 737 max has a new problem, apparently part of the fuselage just popped off mid-flight, no-one injured or worse thankfully: https://www.bbc.co.uk/news/world-us-canada-67899564
Could feed into sentiment affecting downstream aircraft (engine) sales, could plausibly also affect the 737 fleet if it looks like more than an isolated incident.
Well I'm poised to add more if the opening feels right, or if it settles down shortly after. If it just shoots up them I'll sit back and be satisfied watching the existing investment.
The funding being transferred might be priced in (I'd be surprised tho), but yesterday we also got a 40% resource upgrade and written indication of swifter movement to the 2nd, more advanced on-site processing plant (floatation plant) and details of the comprehensive additional/parallel drilling activities. They aren't priced in.
IMO it'll shoot up or stroll up, either way it really should go up. Let's enjoy the ride!
There are 12 individual resolutions to be separately voted for.
E.g. You can vote to remove BT, but you don't have to also vote to add TH, the position on the board could remain vacant until a suitable, qualified, trustworthy individual is proposed.
The company would not fall apart if BT went, but it might be a wake-up call for them. Who really knows...?
Hi NGR, I agree this is an organised concerted attempt to manipulate shareholder opinions by TH and his team, for balance though, today's RNS is likewise from the board.
Neither party has set out details of what they will do with the money to further the company, it's just scare tactics from both sides.
A progressive R&D team at the cutting edge of science should have loads of exciting plans, but most teams struggle for funding. This company has the cash but can't communicate an idea.
For the record, I'm neither fully-for or fully-against all proposals, I'd like to see a limited amount of Board-change. Also, I'm a research scientist (different field, Med Tech) and would have no difficulty using the money ;)
It's amazing how the Board believe the average investor can't think in grey scale!
Personally, I don't think wholesale, sudden change is a sensible course of action, but no changes at all will breed complacency in a potentially inept status quo.
The RNS is amateur, 'think black & white', pressurising scare tactics and pointing out the risks of change whilst ignoring the risks of no change. It does little to build confidence in the current management.
I'm 'in'! Should have bought last week but wanted to do the background research. Listening to the StockBox interview tipped it for me, no hint of dishonesty to be seen.
I also like that they know it's new and they're not afraid to experiment with approaches to roll out (Re. The RNS earlier in the week), this exact one may or may not come off, but they'll learn and grow quickly either way.
Well, I don't like the roll-out... if it's no big deal why sneak it out late in the day, and why only incentivise the guys right at the top? (I work in tech R&D SME's and the assumption that the CxO does 10x more than anyone else and so deserves it is usually incorrect, and that engineers/scientists are not motivated by financial reward is such a fallacy).
But I do agree with you both - it's not a big deal and incentive plans are generally a good thing..., so I'll leave my grumbles be.
Hmmm, not convinced an exercise price equal to the current share price is hugely 'incentivising', it sets the bar for success as like "any raise in share price, however small, is a job well done".
And as for releasing this RNS late in the day (given the content was decided days ago), suggests it's an embarrassing communique they'd like to get away with quietly.
I want this company to succeed, tidal energy needs to succeed, but does the senior leadership have the required passion to drive it forwards? I'm open to being convinced, but am not currently convinced.